Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency

Published:2018-05-22 Issue:1 Volume:101 Page:78-85
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Arcioni Francesco¹,Roncadori Andrea²,Di Battista Valeria¹^ORCID,Tura Sante³,Covezzoli Anna²,Cundari Sante⁴,Mecucci Cristina¹,

Affiliation:

1. Department of Medicine; Institute of Hematology and Center for Hemato-Oncology Research (C.R.E.O.); University of Perugia; Perugia Italy

2. CINECA Interuniversity Consortium; Bologna Italy

3. University of Bologna; Bologna Italy

4. Celgene International Sarl; Milano Italy

Funder

Celgene

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13067/fullpdf

Reference21 articles.

1. Efficacy of lenalidomide in myelodysplastic syndromes;List;N Engl J Med,2005

2. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion;List;N Engl J Med,2006

3. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion dependent patients with low/Intermediate-1-risk myelodysplastic syndromes with del 5q;Fenaux;Blood,2011

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia;Cheson;Blood,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes;Seminars in Hematology;2024-08

2. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment;Seminars in Cancer Biology;2021-01

3. Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide;Case Reports in Transplantation;2020-12-12

4. Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter?;Expert Review of Hematology;2020-02-20

5. Lenalidomide;Reactions Weekly;2018-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3